Q2 2025 |
176 |
$709M |
+$63.2M |
-$39.8M |
+$23.4M |
BBW, CCJ, CLMB, ECG, UFPT
|
13F-HR |
8/13/2025, 11:14 AM |
Q1 2025 |
186 |
$602M |
+$46M |
-$47.7M |
-$1.64M |
BBW, CLMB, MUSA, CCJ, UFPT
|
13F-HR |
5/8/2025, 07:59 AM |
Q4 2024 |
190 |
$682M |
+$84.4M |
-$11.6M |
+$72.9M |
BBW, CLMB, CCJ, MUSA, CLS
|
13F-HR |
2/13/2025, 12:27 PM |
Q3 2024 |
195 |
$617M |
+$145M |
-$22.9M |
+$122M |
BBW, CCJ, UFPT, MBC, CLMB
|
13F-HR |
11/14/2024, 07:14 AM |
Q2 2024 |
177 |
$458M |
+$65.7M |
-$11.3M |
+$54.4M |
CCJ, MUSA, BBW, UFPT, MBC
|
13F-HR |
8/9/2024, 09:56 AM |
Q1 2024 |
152 |
$401M |
$0 |
$0 |
|
CCJ, BBW, MBC, BLDR, MUSA
|
13F-HR |
5/8/2024, 08:46 AM |